Table 2.
Univariate analysis | |||
---|---|---|---|
Variable | OR | 95% CI | p |
Sex | 1.27 | 0.47–3.46 | 0.63 |
Age | 1.01 | 0.97–1.05 | 0.60 |
Indication for catheter insertion: incident/prevalent renal failure | 0.79 | 0.25–2.53 | 0.69 |
ASA use | 0.95 | 0.30–3.04 | 0.93 |
LMWH use | 5.26 | 0.86–32.09 | 0.07 |
HCH group assignment | 3.12 | 1.08–9.02 | 0.03 |
Femoral localization | 3.32 | 0.88–12.57 | 0.07 |
Side of catheter insertion | 1.33 | 0.35–4.99 | 0.67 |
HGB | 1.10 | 0.83–1.44 | 0.50 |
PLT | 1.00 | 0.99–1.01 | 0.88 |
FBG | 1.00 | 0.99–1.00 | 0.15 |
Baseline APTT | 1.13 | 1.02–1.25 | 0.02 |
Baseline INR | 0.46 | 0.01–39.74 | 0.73 |
APTT 2 h after catheter insertion | 1.03 | 1.01–1.05 | 0.002 |
APTT activated partial thromboplastin time, ASA use of acetylsalicylic acid, CI confidence interval, FBG fibrinogen, HCH high concentration of heparin, HGB hemoglobin, INR international normalized ratio, LMWH use of low molecular weight heparin, OR odds ratio, PLT platelet count